Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Klaus Cichutek

Showing results (1-10 of 72) with videos related to

Pageof 8
Sort By:
Pharmazie in Unserer Zeit|June 24, 2011
[Clinical application of gene therapy. Previous experience and the future]Barbara Langer, Klaus Cichutek
The Journal of Gene Medicine|September 27, 2006
Is it going to be SIN?: a European Society of Gene Therapy commentary. Phasing-out the clinical use of non self-inactivating murine leukemia virus vectors: initiative on holdChristian J Buchholz, Klaus Cichutek
Methods in Molecular Biology (Clifton, N.J.)|December 27, 2008
The US and EU regulatory perspectives on the clinical use of hematopoietic stem/progenitor cells genetically modified ex vivo by retroviral vectorsCarolyn A Wilson, Klaus Cichutek
Pharmazie in Unserer Zeit|December 18, 2007
[Trends in vaccine development]Jürgen Scherer, Thomas Hinz, Klaus Cichutek
Trends in Biotechnology|March 31, 2009
Lentiviral vectors with measles virus glycoproteins - dream team for gene transfer?Christian J Buchholz, Michael D Mühlebach, Klaus Cichutek
The Journal of General Virology|May 13, 2006
Envelope proteins of spleen necrosis virus form infectious human immunodeficiency virus type 1 pseudotype vector particles, but fail to incorporate upon substitution of the cytoplasmic domain with that of Gibbon ape leukemia virusJörn Stitz, Nina Wolfrum, Christian J Buchholz, et al.
Virology|December 31, 2002
Displaying epidermal growth factor on spleen necrosis virus-derived targeting vectorsChristoph A Merten, Martin Engelstaedter, Christian J Buchholz, et al.
Methods in Molecular Biology (Clifton, N.J.)|October 30, 2012
Safety assessment of biolistic DNA vaccinationBarbara Langer, Matthias Renner, Jürgen Scherer, et al.
Human Gene Therapy|July 15, 2010
Do CARs need a driver's license? Adoptive cell therapy with chimeric antigen receptor-redirected T cells has caused serious adverse eventsHildegard Büning, Wolfgang Uckert, Klaus Cichutek, et al.
Human Gene Therapy|May 30, 2008
Good clinical practice in the European UnionImmanuel Barth, Hartmut Krafft, Gabriele Weber, et al.
Pageof 8

Showing results (1-10 of 72) with videos related to

Sort By:
Pageof 8
Pharmazie in Unserer Zeit|June 24, 2011
[Clinical application of gene therapy. Previous experience and the future]Barbara Langer, Klaus Cichutek
The Journal of Gene Medicine|September 27, 2006
Is it going to be SIN?: a European Society of Gene Therapy commentary. Phasing-out the clinical use of non self-inactivating murine leukemia virus vectors: initiative on holdChristian J Buchholz, Klaus Cichutek
Methods in Molecular Biology (Clifton, N.J.)|December 27, 2008
The US and EU regulatory perspectives on the clinical use of hematopoietic stem/progenitor cells genetically modified ex vivo by retroviral vectorsCarolyn A Wilson, Klaus Cichutek
Pharmazie in Unserer Zeit|December 18, 2007
[Trends in vaccine development]Jürgen Scherer, Thomas Hinz, Klaus Cichutek
Trends in Biotechnology|March 31, 2009
Lentiviral vectors with measles virus glycoproteins - dream team for gene transfer?Christian J Buchholz, Michael D Mühlebach, Klaus Cichutek
The Journal of General Virology|May 13, 2006
Envelope proteins of spleen necrosis virus form infectious human immunodeficiency virus type 1 pseudotype vector particles, but fail to incorporate upon substitution of the cytoplasmic domain with that of Gibbon ape leukemia virusJörn Stitz, Nina Wolfrum, Christian J Buchholz, et al.
Virology|December 31, 2002
Displaying epidermal growth factor on spleen necrosis virus-derived targeting vectorsChristoph A Merten, Martin Engelstaedter, Christian J Buchholz, et al.
Methods in Molecular Biology (Clifton, N.J.)|October 30, 2012
Safety assessment of biolistic DNA vaccinationBarbara Langer, Matthias Renner, Jürgen Scherer, et al.
Human Gene Therapy|July 15, 2010
Do CARs need a driver's license? Adoptive cell therapy with chimeric antigen receptor-redirected T cells has caused serious adverse eventsHildegard Büning, Wolfgang Uckert, Klaus Cichutek, et al.
Human Gene Therapy|May 30, 2008
Good clinical practice in the European UnionImmanuel Barth, Hartmut Krafft, Gabriele Weber, et al.
Pageof 8